Eptinezumab for adolescents with chronic refractory headache: A retrospective chart review.

Natalia ZorrillaAmy A GelfandSamantha L Irwin

Published in: Headache (2023)

While this was a small sample, findings suggest that eptinezumab may be a safe and effective treatment for chronic, refractory headache in adolescents.

Keyphrases

young adults
physical activity
drug induced
smoking cessation
replacement therapy